Innovative Automated Insulin Delivery System for Type 2 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 14, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions
Type 2 DiabetesInsulin Treated Type 2 Diabetes Mellitus
Interventions
DEVICE

twiist insulin delivery system

twiist system includes a novel insulin pump, a CGM sensor and the DEKA Loop algorithm

Trial Locations (24)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

10032

NOT_YET_RECRUITING

Naomi Berrie Diabetes Center, New York

13210

RECRUITING

SUNY Upstate Medical University, Syracuse

21201

RECRUITING

University of Maryland, Baltimore

27599

NOT_YET_RECRUITING

University of North Carolina, Chapel Hill

30076

RECRUITING

Endocrine Research Solutions, Inc, Roswell

37411

RECRUITING

University Diabetes & Endocrine Consultants, Chattanooga

43210

RECRUITING

The Ohio State University, Columbus

46202

RECRUITING

IU Health University Hospital, Indianapolis

48109

NOT_YET_RECRUITING

University of Michigan, Ann Arbor

48202

RECRUITING

Henry Ford Health, Detroit

50265

RECRUITING

Iowa Diabetes & Endocrinology Research Center, West Des Moines

55416

RECRUITING

International Diabetes Center - Health Partners Institute, Minneapolis

55905

RECRUITING

Mayo Clinic, Rochester

60077

RECRUITING

Endeavor Health, Skokie

78731

RECRUITING

Texas Diabetes & Endocrinology, P.A., Austin

83404

RECRUITING

Rocky Mountain Clinical Research, LLC, Idaho Falls

84093

RECRUITING

Diabetes & Endocrine Treatment Specialists, Sandy City

92037

RECRUITING

Scripps Whittier Diabetes Institute, La Jolla

92663

RECRUITING

Hoag Memorial Hospital Presbyterian, Newport Beach

93111

RECRUITING

Sansum Diabetes Research Institute, Santa Barbara

02114

RECRUITING

Massachusetts General Hospital, Boston

02118

RECRUITING

Boston Medical Center, Boston

02215

RECRUITING

Joslin Diabetes Center, Boston

Sponsors
All Listed Sponsors
lead

Deka Research and Development

INDUSTRY

collaborator

Sequel Med Tech

UNKNOWN